Portland, Ore.-based OHSU voluntarily suspended its transplant program last August after all four of the program’s cardiologists resigned for unspecified reasons.
Since then, OHSU has hired three advanced heart failure cardiologists to join the program. On Aug. 26, the United Network for Organ Sharing approved the program’s new primary physician for heart transplantation, which will allow the transplant program to resume operations.
“OHSU’s Heart Transplant Program has a long history of serving the state of Oregon, providing more than 700 heart transplant procedures to date,” OHSU President Danny Jacobs, MD, said in a news release. “With the successful recruitment of cardiologists from some of the preeminent programs in the country, we are pleased to resume the full spectrum of care for Oregonians with advanced heart failure, in need of heart transplantation.”
More articles on clinical leadership & infection control:
Public charge rule may deter immigrants from vaccinating kids, health officials say
Jewish Hospital cancels suspension of Louisville heart transplant program
1st death reported amid uptick in vaping-related illnesses
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
